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Abstract
Introduction: Mesenchymal stem cells (MSCs) offer promise for intervertebral disc (IVD) repair and regeneration 
because they are easily isolated and expanded, and can differentiate into several mesenchymal tissues. Notochordal 
(NC) cells contribute to IVD development, incorporate into the nucleus pulposus (NP), and stimulate mature disc cells. 
However, there have been no studies investigating the effects of NC cells on adult stem cell differentiation. The premise 
of this study is that IVD regeneration is more similar to IVD development than to IVD maintenance, and we hypothesize 
that soluble factors from NC cells differentiate MSCs to a phenotype characteristic of nucleus pulposus (NP) cells during 
development. The eventual clinical goal would be to isolate or chemically/recombinantly produce the active agent to 
induce the therapeutic effects, and to use it as either an injectable therapy for early intervention on disc disease, or in 
developing appropriately pre-differentiated MSC cells in a tissue engineered NP construct.
Methods: Human MSCs from bone marrow were expanded and pelleted to form high-density cultures. MSC pellets 
were exposed to either control medium (CM), chondrogenic medium (CM with dexamethasone and transforming 
growth factor, (TGF)-β3) or notochordal cell conditioned medium (NCCM). NCCM was prepared from NC cells 
maintained in serum free medium for four days. After seven days culture, MSC pellets were analyzed for appearance, 
biochemical composition (glycosaminoglycans and DNA), and gene expression profile (sox-9, collagen types-II and III, 
laminin-β1 and TIMP1(tissue inhibitor of metalloproteinases-1)).
Results: Significantly higher glycosaminoglycan accumulation was seen in NCCM treated pellets than in CM or TGFβ 
groups. With NCCM treatment, increased gene expression of collagen III, and a trend of increasing expression of 
laminin-β1 and decreased expression of sox-9 and collagen II relative to the TGFβ group was observed.
Conclusions: Together, results suggest NCCM stimulates mesenchymal stem cell differentiation toward a potentially 
NP-like phenotype with some characteristics of the developing IVD.
Introduction
The developing intervertebral disc (IVD) is formed as a
result of an interaction between mesenchymal and noto-
chordal (NC) cell types. For many organisms, NC cells
disappear from the nucleus pulposus (NP) with aging and
are replaced with chondrocyte-like cells, possibly sug-
gesting an important functional role for NC cells during
development. The age that NC cells disappear varies with
animal species, although some species, such as pig, retain
NC cells in maturity [1]. In humans, the loss of NC cells
occurs at a very young age [2-5]. Disappearance of NC
cells may contribute to matrix changes, typically charac-
terized by a transition from a healthy gelatinous structure
to a fibrous composition similar to that of the surround-
ing annulus fibrosus (AF) tissue, as well as decreases in
cellularity during aging [6,7]. The NP tissue of NC cell
retaining species is easily distinguished from that of non-
NC cell retaining species by its higher proteoglycan and
water content and a generally less fibrous nature [6].
NC cells have been morphologically described as being
rounded, larger than NP cells, containing vacuoles, and
with an extensive cytoskeletal network [1,8-10]. Recent
studies have further defined the NC cell phenotype by
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Page 2 of 8successfully sorting them from the smaller NP cells using
fluorescence-activated cell sorting (FACS) [7]. Although
no specific marker(s) exists for the NC or NP cell types,
their obvious size differences allow for successful separa-
tion by fluorescence-activated cell sorting based on side
scatter and forward scatter parameters. The ability to
separate the NC and NP cells also allowed for the first
accurate comparisons of their respective gene expression
profiles, and comparison to AF cells from the same ani-
mals [7].
Mesenchymal stem cells (MSCs) are adult tissue
derived progenitor cells that exhibit clonogenicity,
extended proliferative activity, and the ability to undergo
multi-lineage differentiation [11]. The differentiation of
MSCs into a chondrocyte phenotype through culture
maintenance in a chondrogenic medium, specifically the
supplementation of TGFβ, has been well documented
[12]. A specific requirement for MSC chondrogenic dif-
ferentiation in vitro is high cell density, for example in a
three-dimensional pellet culture. While the phenotypic
difference between chondrocytes and NP cells is a source
of debate, it is clear that NP cells and chondrocytes share
many common characteristics, such as expression of col-
lagen type II and aggrecan, and it is likely that three-
dimensional pellet culture is likewise a requirement for
NP cell differentiation.
The current lack of specific marker(s) for IVD cells lim-
its the ability to meaningfully explore the differentiation
of MSCs to an IVD phenotype. In addition to studying
MSC differentiation using more traditional chondrogenic
markers of aggrecan, SRY-box 9 (SOX9), and collagen
type II, this study sought to probe for expression of candi-
date markers referenced in the literature that together
indicate a phenotype of cells unique to the IVD regions.
In this study, we looked at three additional protein tran-
scripts shown to be distinctly expressed in IVD tissues,
collagen type III, laminin β1 and tissue inhibitor of metal-
loproteinases-1 (TIMP1). Collagen type III is the first col-
lagen type expressed in the developing NP of the rat [13]
and has been reported to be present in the NP and AF
regions during both human and rat IVD development
[14]. Another member of the laminin family, laminin γ1,
is present in the developing NP and inner AF regions,
with localization primarily peripheral in the early NP
(E15/16) but present later in the NP and AF (E20) [13].
NP cells exhibit preferred adhesion to laminin γ1 coated
culture plates relative to AF cells [15]. TIMP1 has been
shown to be present in NC cell conditioned medium
(NCCM) by mass spectroscopy [16] and is highly differ-
entially expressed by NC, NP and AF cells [7].
The fundamental premise of this study is that IVD
regeneration is more similar to IVD development than to
IVD maintenance, with the corollary that NC cells are
likely to be important contributors to the process of
regeneration. The purpose of this study was thus to begin
to investigate if NC cells may be used to recapitulate the
developmental stages in the IVD by differentiating MSCs,
a promising candidate cell type for tissue regeneration, to
a phenotype with characteristics of the developing NP. As
no phenotypic markers currently exist to distinguish NP
cells from chondrocytes, we probed expression of some
genes found to be present during IVD development in an
attempt to distinguish MSC differentiation by TGFβ3
from that by NCCM. We hypothesized that NC cell con-
ditioned medium will promote differentiation of MSCs
toward a generally chondrogenic phenotype that is dis-
tinct from that induced using a TGFβ based chondro-
genic medium, and with characteristics similar to NP
cells. Should NCCM contain soluble factors that differen-
tiate MSCs to a NP phenotype, the eventual clinical goal
would be to isolate or chemically/recombinantly produce
the active agent to induce the therapeutic effects, and to
use it either as an injectable therapy for early intervention
on disc disease, or in developing appropriately pre-differ-
entiated MSC cells in a tissue engineered NP construct.
Materials and methods
Preparation of notochordal cell conditioned medium
The NP and AF regions from five porcine spines (approx-
imately 10 intervertebral discs, from lower cervical, tho-
racic and lumbar regions as available, average age
approximately two years) were separated from the sur-
rounding tissue and cultured in vitro at 37°C and 5% CO2
in washing medium (modified from [17]) consisting of
high glucose Dulbecco's Modified Eagle Medium
(DMEM) with 10% fetal bovine serum (FBS), 100 μg/mL
kanamycin, 200 U/ml penicillin and streptomycin, 0.50
μg/ml amphotericin-B (Sigma-Aldrich, St. Louis, MO,
USA) and 0.5% v/v 5 M NaCl and 0.4 M KCl to adjust
medium osmolarity to simulate the IVD environment. In
general, medium was only supplemented with FBS to
help cells recover from procedural steps and all medium
used for conditioning of MSCs was serum free. After four
days of culture to ensure no microorganism contamina-
tion was present, the tissue explants were separated by
centrifugation and the supernatant was removed. The tis-
sue was then pooled by tissue region, minced, and
digested following a previously published protocol [17].
Pronase at 0.4% (w/v) for the AF or 0.2% for the NP (EMD
Biosciences, Gibbstown, NJ, USA) was added to high glu-
cose DMEM with 5% FBS for one hour with gentle agita-
tion at 37°C, followed by four to six hours of digestion
with collagenase type II at 0.2% for the NP, 0.4% for the
AF (Worthington Biochemical, Freehold, NJ, USA) again
in high glucose DMEM with 5% FBS. The resulting cell
suspensions were passed through a 70 μm cell sieve and
washed three times by centrifugation at 300 g with phos-
phate buffered saline (PBS).
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separate the large NC cells from the small NP cells of the
NP tissue fraction [7]. Due to the complexity of the FACS
set-up, the tissue from the five pig spines was pooled for
sorting. Both AF and NP cell suspensions were washed
once with 1× non-enzymatic cell dissociation solution
(Sigma-Aldrich, St. Louis, MO, USA). Cell suspensions
were then centrifuged at 300 g, the supernatant was
removed, and cells resuspended in FACS buffer (phos-
phate buffered saline, PBS, with 0.1% FBS) and placed on
ice prior to FACS. The sorting protocol was based on a
previously published protocol that analyzed forward scat-
ter (FSC) and autofluorescence parameters [7]. The large
NC cells, small NP cells and AF cells were retained and
sorted into 100% FBS on ice.
Following sorting, all cell suspensions were pelleted by
centrifugation, resuspended in medium (high glucose
DMEM with 10% FBS, 100 U/ml penicillin and strepto-
mycin, 0.25 μg/ml amphotericin-B, and 0.5% v/v 5 M
NaCl and 0.4 M KCl) and plated for visual confirmation
of sort efficacy (that is, only NC or NP cells in the correct
category). The NC cells were then retained and incubated
overnight in medium (high glucose DMEM with 10%
FBS, 100 U/ml penicillin and streptomycin, 0.25 μg/ml
amphotericin-B, and 0.5% v/v 5 M NaCl and 0.4 M KCl)
at 5% O2 and CO2, 37°C to recover. The next day, cells
were seeded into alginate gels at 2 × 106 cells/mL and cast
into discs (height of 3.27 ± 0.15 mm and diameter of 5.82
± 0.22 mm, using 100 μL of alginate-gel solution) using a
slow set technique [18]. Alginate culture was used to
maintain a three-dimensional culture environment for
the NC cells.
NCCM was produced with five gels placed into each
well of a six-well non-treated tissue culture plate and
incubated in 5 mL of serum free medium (high glucose
DMEM, 100 U/ml penicillin and streptomycin, 0.25 μg/
ml amphotericin-B, and 0.5% v/v 5 M NaCl and 0.4 M
KCl). Therefore, the starting cell density of the resulting
conditioned medium NCCM was 1,000,000 NC cells per
5 mL medium. The cultures were maintained for four
days. The nature of the NCCM was confirmed by exami-
nation of the cytomorphology and viability of NC cells
following release from alginate. The retention of NC cell
cytomorphology was confirmed by comparing released
cells with images obtained before alginate embedding,
and with descriptions of NC cells in the published litera-
ture [1,7]. Viability was assessed using the LIVE/DEAD
assay (Molecular Probes, Eugene, OR, USA), where cells
were incubated in 4 mM Calcein-AM and 2 mM Ethid-
ium homodimer-1 in PBS to determine numbers of live
and dead cells, respectively. The NCCM was then frozen
and stored for future use by direct application to human
MSCs derived from three different patients in three sepa-
rate experiments as described below.
Isolation and differentiation of human MSCs
Human MSCs were harvested with informed consent
from the bone marrow of three patients undergoing total
hip replacement surgery (University of Washington;
mean age 64.3, range 56 to 73) as described previously
[19,20]. Briefly, bone marrow was flushed from the bone
with high glucose DMEM then centrifuged once to
remove the fat containing layer. The remaining suspen-
sion was then layered on a Ficoll-Paque density gradient
(Amersham, Uppsala, Sweden) to isolate the mononu-
clear cells and plated onto tissue culture polystyrene
flasks. After 24 hours, cultures were washed with PBS to
remove non-adherent cells and material. Adherent MSCs
were culture-expanded to passage 3 or 4 in high glucose
DMEM with 100 U/ml penicillin and streptomycin, 0.25
μg/ml amphotericin-B and 10% FBS.
MSCs cell pellets consisting of approximately 250,000
cells were created in 96-well conical bottom plates (Nunc,
Rochester, NY, USA). Pellets were incubated overnight in
serum-free control medium (CM: high glucose DMEM,
1% ITS + premix, 50 μg/mL L-ascorbic acid 2-phospate,
40 μg/mL L-proline, 100 mg/mL sodium pyruvate) after
which they were assigned to one of three groups: NCCM
(applied directly without dilution), CM, or TGFβ (CM
with 10 ng/mL recombinant human TGF-β3 (R & D sys-
tems, Minneapolis, MN, USA) and 100 nM dexametha-
sone). For each group, the culture medium was changed
at the beginning of the seven day experiment and on Day
3 of culture. Pellets were maintained at 37°C and 5% CO2
and at 5% O2 to replicate the low oxygen tension present
in the IVD.
After seven days in culture, the cell pellets were har-
vested and analyzed for sulfated glycosaminoglycans
(sGAG) using the Blyscan assay kit (Accurate Chemical,
Westbury, NY, USA) and DNA content using the
Picogreen assay (Molecular Probes, Eugene, OR, USA).
Pellets were flash-frozen, sectioned, and stained with
Alcian blue to visualize sGAG distribution and content.
To evaluate the differentiation state of the cells in pellets,
total RNA was extracted using Trizol (Invitrogen, Carls-
bad, CA, USA) according to the manufacturer's instruc-
tions. The gene expression profile was analyzed using
quantitative reverse transcription-polymerase chain reac-
tion (qRT-PCR) using human gene-specific primers and
SYBR Green fluorophore: Collagen type II (F -
AAGAAGGCTCTGCTCATCCAGG, R - TAGTCTT-
GCCCCACTTACCGGT) and collagen type III (F - TCT-
TCCTGGTCTGGCTGGTA, R - TCCTCGAT
GTCCTTTGATGC), SOX9 (F - TGAAGAAGGAGAGC-
GAGGAG, R - GTCCAGTCGTAGCCCTTGAG),
TIMP1 (F - TACACCCCCGCCATGG, R - GTCCA-
CAAGCAATGAGTG) and laminin β1 (F - AAGGAA-
GACGGGAAGAAAGGG, R - TACAGTAGGGTTCGG
GCTTGTG). mRNA transcripts were quantified and lev-
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dehydrogenase (GAPDH) (F - ATCAAGAAGGTGGT-
GAAGCAGG, R - TGAGTGTCGCTGAAGTCG). The
results were also normalized to CM conditions, and Stu-
dent's t-test was used to identify statistically significant
differences between NCCM and TGFβ medium condi-
tions (significance level of P < 0.05).
Results
The sorting protocol was based on a previously published
protocol that analyzed forward scatter (FSC) and autoflu-
orescence parameters [7], with the exception that in our
hands, autofluorescence was not found to be consistently
distinguishable between small and large NP cells so this
step was omitted. The AF cells were used as a reference
gate population where pulse width and FSC were used to
set the gate, followed by introduction of the NP/NC cell
population and separation of the small NP cells (match-
ing the reference gate population of the AF) and the large
NC cells (larger pulse width and higher on average FSC
parameter than the gate population) (Figure 1).
After culture for four days in alginate, NC cells released
from the alginate showed no decrease in viability or
changes in morphological appearance (Figure 2a, b, c, d),
supporting the use of alginate culture for future studies of
NC cells. This is in contrast to NC cell morphology in
monolayer, where the cells spread extensively and lose
their morphological appearance of rounded cells with
internalized vacuoles. These observations suggest that
the NC cells retained their viability as well as phenotype
in 3-D culture. Thus the NCCM represented a valid
reagent to test the biological activity of secreted products
of NC cells.
We next examined the effects of exposure to NCCM on
the differentiation activities of human bone marrow
MSCs in high density pellet culture as compared to TGFβ
treatment. In terms of gross morphology, MSC pellets
cultured in either TGFβ medium or NCCM were always
visually larger compared to those cultured in CM, how-
ever the relative sizes of NCCM and TGFβ pellets varied
between patients (Figure 3c). Biochemical analysis
showed that GAG production (normalized to DNA con-
tent, which was not significantly different between
groups) was enhanced in both NCCM and TGFβ cultures
relative to CM cultures, with NCCM treatment signifi-
cantly more effective than TGFβ treatment (10 ng/mL
TGFβ3 and 100 nM dexamethasone) (Figure 3a). Culture
in NCCM resulted in approximately 2.5 fold greater GAG
accumulation than culture in CM, and also resulted in
significantly greater accumulation of GAG than culture in
TGFβ medium (P < 0.05). Histological images also
showed more qualitative Alcian blue staining of sGAG in
NCCM and TGFβ treated groups than in the CM group
(Figure 3b).
Figure 1 Schematic of experimental design to produce NCCM. NP tissue from the porcine IVD was harvested and digested to obtain a mixture of 
large NC and small NP cells. Large NC cells were isolated from the mixture by FACS (top FACS image is combined NC/NP cells with the reference gate 
to select NC cells, bottom FACS image is the isolated cells from the gate (NC cells). NC cells were embedded in alginate, and cultured for four days to 
produce conditioned medium (NCCM).
Korecki et al. Stem Cell Research & Therapy 2010, 1:18
http://stemcellres.com/content/1/2/18
Page 5 of 8NCCM and TGFβ had distinct effects on the expression
levels of a number of genes relevant to chondrocyte and
NP cell phenotype. We examined mRNA expression lev-
els at a relatively early time point (Day 7 of culture) in
order to assess and compare the early differentiation
response of MSCs to both NCCM and TGFβ treated
medium. Gene expression levels of collagen type II and
SOX9, indicative of hyaline chondrocytes, were not
upregulated as strongly in NCCM treated samples as
TGFβ samples (Figure 4a). Gene expression for collagen
type III was significantly up-regulated in NCCM versus
TGFβ treated MSCs (P < 0.05) (Figure 4b). Laminin β1
gene expression tended to be higher in NCCM than
TGFβ, however results were not statistically significant.
No trends in TIMP1 expression were detected.
Discussion
In this study we examined the possible trophic activity of
NC cells by analyzing the effects of NCCM on the differ-
entiation response of multipotent human MSCs in com-
parison to the response of MSCs to control medium or
medium containing TGFβ and dexamethasone. Consis-
tent with our hypothesis, NCCM promoted a phenotype
in pellet cultures of MSCs that was distinct from that
observed in cultures maintained in TGFβ and dexame-
thasone containing medium. Phenotype characteristics of
NCCM-treated cells that are reminiscent of IVD develop-
ment include a significant upregulation of collagen type
III mRNA expression, a trend of increased laminin β1
mRNA expression, and significantly higher level of sGAG
production than for TGFβ treated cells. In addition,
NCCM conditioning of MSCs tended to up-regulate col-
lagen type II mRNA less strongly than with TGFβ. Taken
together, these results highlight the differences between
the NCCM-induced phenotype and the chondrogenic
phenotype induced by TGFβ, and suggest that NCCM
Figure 2 Viability and morphology of NC cells embedded in alg-
inate and cultured for four days. Cell viability (a, c) was assessed us-
ing LIVE/DEAD staining and morphology (b, d) was observed by 
means of phase contrast microscopy. Cells retained viability and mor-
phology after FACS (a, b) and after being embedded in alginate for four 
days (c, d). Cell viability dyes are calcein AM (green) and ethidium ho-
modimer red (red). Scale bar = 200 microns.
Figure 3 Morphology and sGAG production in MSC pellet cultures treated with NCCM and TGFβ. Cultures were examined after seven days of 
treatment. A) Significantly greater GAG production was noted in the NCCM than TGFβ group (* indicates significance, P = 0.04). Values are expressed 
as average ±SEM. sGAG/DNA normalized to CM group. B) Pellets stained with alcian blue and imaged at 20× show an increase in sGAG content with 
NCCM treatment. (L to R: CM, TGFβ medium, NCCM) Scale bar = 200 microns. C) NCCM and TGFβ treated pellets were larger than control pellets as 
analyzed by gross morphology (L to R: CM, TGFβ medium, NCCM) scale bar = 1.8 mm.
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phenotype.
A rigorous distinction of IVD cells from chondrocytes
does not currently exist, despite evidence of phenotypic
differences [21], due to a lack of unique cell surface mark-
ers or other definitive cellular characteristics. Therefore,
with current scientific knowledge, NC cells and NP cells
must be characterized morphologically and based on
multiple protein and gene measurements. In an attempt
to assess the possible IVD characteristics of NCCM-
treated MSCs, expression levels of collagen type III
(shown to be expressed early in NP tissue development
[13]), laminin β1 (also found during early NP tissue devel-
opment [13] and in the NP and inner AF of immature
porcine spines [15]), and TIMP1 (shown to be differen-
tially expressed in NC cells versus NP and AF cells [7])
were examined in this study in addition to the typical
chondrocyte markers of SOX9 and collagen type II. Col-
lagen type III clearly has a role in IVD development as it
has been reported to be present in outer AF, inner AF,
and NP regions during human [19] and rat IVD develop-
ment [13]. It is the first collagen type expressed in the
developing NP of the latter [13]. Immunoreactive colla-
gen type III is strongly detected in the outer and inner AF
regions in the neonate [13] finally localizing pericellularly
in the outer AF [22]. However, increased collagen type III
has also been reported pericellularly in degenerating
discs [23] so that it may also be present during attempted
repair or other degenerative processes. While increased
collagen type III expression was observed by qRT-PCR in
this study, no collagen type III was detected using immu-
nohistochemical staining (data not shown), which could
be the low level of protein accumulation during the time
course used here. Laminin chains have been reported to
be present in the developing and functional IVD. Laminin
γ1 is present in the developing NP and inner AF regions,
with localization primarily in the early NC (E15/16), but
present later in the NP and AF (E20) [13]. NP cells attach
to laminin γ1 coated plates in higher numbers than AF
cells, indicating a cell phenotype-dependent role of this
molecule in cell-matrix attachment [15]. Although no
statistically significant increase in the expression of
another member of the laminin family (laminin β1) was
observed in NCCM-treated MSC pellet cultures, a trend
of increasing expression was observed. Future work
should examine the presence of other laminin chain iso-
forms, particularly as the role and importance of these
extracellular matrix molecules is clarified. TIMP1 has
also been shown to be highly differentially expressed by
NC, NP and AF cells [7] and has been shown to be pres-
ent in NCCM by mass spectroscopy analysis [16]. How-
ever, no difference between the expression levels of
TIMP1 was observed between MSCs exposed to NCCM
or TGFβ medium in this study.
Our results demonstrate that NCCM and TGFβ have
compellingly different capacities to differentiate MSCs
along chondrogenic pathways, and with notable distinc-
tions. This study provides a first step for exploring how
NC cells may contribute to future strategies for MSC
based IVD regeneration. Yet some limitations should be
considered that require additional investigation, particu-
larly with respect to the specific mechanisms of action.
For example, it is possible that NC cell secreted sGAG
may have been present in the NCCM conditioned
medium and been delivered to the MSC pellets. This may
have contributed to the sGAG measured in the NCCM
treated group; however, the pellets for the NCCM group
always appeared large, suggesting that this would at most
account for only a partial effect. The absence of a control
cell conditioned medium group (such as a fibroblast con-
Figure 4 qRT-PCR analysis of MSC pellet cultures treated with NCCM or TGFβ. Expression of genes associated with chondrocyte or NP pheno-
types were measured. Data were averaged over three patients, normalized to GAPDH and expressed relative to CM values (average +/- SEM). * indi-
cates significantly greater collagen III expression in NCCM relative to TGFβ medium (P < 0.05).
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ditioned medium, or conditioned medium from other
cells of the IVD such as AF or NP cells), while not affect-
ing the comparison between NCCM and chondrogenic
medium treated cells, limits identification of unique con-
tributions of NP cells to MSC differentiation. In addition
to the production of soluble factors, NC cells could also
have depleted some nutrients or essential factors in the
NCCM. Taken together, our results highlight the poten-
tial for NCCM to stimulate MSC differentiation, and
future investigations are required to establish mecha-
nisms of these effects including longer duration studies
and the addition of hypertrophic markers.
Previous studies have illustrated the stimulatory effects
of NC cell conditioned medium on native IVD cells and
chondrocytes [8,16,24,25]. Mass spectroscopic analysis
has shown the presence of connective tissue growth fac-
tor (CTGF) in NCCM [24], suggesting a mechanism for
the NC cell mediated change in IVD and chondrocyte cell
metabolism. CTGF has been shown to be an important
factor in cell proliferation and matrix remodeling during
chondrogenesis [26], motivating future investigation
along with other possible factors responsible for IVD cell
specific differentiation.
Conclusions
This study demonstrates that NC cells secrete soluble fac-
tor(s) that stimulate MSC differentiation down a lineage
different from standard mesenchymal chondrogenesis.
Specifically, NCCM induced significantly more collagen
type III expression and sGAG production in MSCs,
which when taken in the context of IVD development,
may be an indication that NCCM induces a more NP-like
phenotype than chondrogenic medium containing
TGFβ3 and dexamethasone. Thus, we propose that NC
cells may serve to maintain the young NP phenotype of
IVDs in species that retain NC cells, and that this charac-
teristic makes NC cells a promising target cell type to for-
mulate approaches for IVD repair that may have
similarities to development, and the potential for NCCM
to influence MSC differentiation offers promise. While
further research is needed to define an NP phenotype ver-
sus a chondrocyte phenotype before definitive conclusions
can be drawn as to the differentiation profile of the
MSCs, collagen III and laminin isoforms may provide
useful markers in this distinction. Determining the mech-
anisms responsible for the NCCM effect will be critical in
developing MSC based therapies for IVD repair.
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